Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR ® (deutetrabenazine) extended-release tablets Patients reported ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Out-of-pocket costs and dosing frequency play a big part ...
In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO ...
Add Yahoo as a preferred source to see more of our stories on Google. John Whipps, who took part in clinical trials for the treatment, pictured with his wife Sue Advanced Parkinson’s sufferers in ...
HRD-positive tumors derived the largest median PFS gain with rucaparib maintenance versus placebo, consistent with PARP ...
New York City-based Health Recovery Solutions raised $1 million from undisclosed investors, the company's COO Rohan Udeshi told MobiHealthNews. This brings the company's total funding to $1.8 million.
The NHS has issued a cautionary note on its website for those taking a common medication for high blood pressure. Also known as hypertension, this medical condition affects approximately one in three ...
Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care: Our Bureau, Mumbai Wednesday, March 18, 2026, 15:40 Hrs [IST] Akums Drugs & Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results